Generic Drug News and Research

RSS

Generic Drugs are official nonbrand names by which medicines are known. Generic names usually refer to the chemical name of the drug.

Bird flu strikes again in Thailand

The death of a 59-year-old farmer in northeastern Thailand last month has taken the countries death toll from bird-flu to 17 since late 2003 and is the third death this year.

27 Sep 2006

Roche to transfer technology for Saquinavir to three generic drug companies in Africa

Switzerland-based pharmaceutical company Roche on Friday said it will provide three generic drug companies in sub-Saharan Africa assistance in producing the protease inhibitor saquinavir under its Technology Transfer Initiative, Reuters South Africa reports (Reuters South Africa, 9/22).

26 Sep 2006

Prices on medications most commonly used by older people rose 4.3% in first half of 2006

Manufacturer prices for the brand-name drugs most commonly used by individuals ages 50 and older increased by an average of 6.3% during the 12-month period ending in June, according to an AARP survey released on Tuesday, the Newark Star-Ledger reports.

22 Sep 2006

Combating generics: pharmaceutical brand defense for 2007

Court cases regarding patent infringement effectively slow generics in coming to market, however US lawmakers and FDA continue to make it easier for generic drugs to gain approval (Cutting Edge Information).

21 Sep 2006

Insurance companies promote use of generic drugs in effort to cut costs

The Chicago Tribune on Sunday examined how some private insurers, in an attempt to reduce health care costs by encouraging the use of generic drugs, "are showering customers with free generic drug samples, waiving copayments and marketing directly to consumers in doctors' offices."

20 Sep 2006

Studies on effects of drugs on children often not published

According to a new study by researchers at Duke University Medical Center, many of the drugs that are prescribed for children may not in fact be either safe or effective for pediatric use and could require different doses than is recommended.

13 Sep 2006

Accutane iPledge program requirements leading to illegal online sales

The strict regulations governing the prescription and use of the acne drug isotretinoin, sold by Roche under the brand name Accutane, are affecting the drug's sale and dispensation and raising concerns about sales of the medication over the Internet, the Wall Street Journal reports (Corbett Dooren, Wall Street Journal, 9/12).

13 Sep 2006

Department of Justice joins Whistleblower lawsuit alleging overcharging by drug company Dey

The Department of Justice on Monday joined a whistleblower lawsuit filed against California-based Dey, a generic medication division of Germany-based Merck KGaA, over allegations that the company inflated prices reported to federal health insurance programs, the Boston Globe reports.

13 Sep 2006

FDA approves Watson's generic version of Barr's contraceptive pill Seasonale

FDA on Thursday approved Watson Pharmaceuticals' marketing application for its generic version of Barr Laboratories' extended-cycle oral contraceptive Seasonale, Reuters reports.

11 Sep 2006

Western nations have not adequately addressed Africa's HIV/AIDS epidemic because of 'subterranean racism'

Western nations have not taken sufficient action to address the HIV/AIDS epidemic in Africa because of "some kind of subterranean racism," U.N. Special Envoy for HIV/AIDS in Africa Stephen Lewis said in Ottawa on Wednesday, the Ottawa Citizen reports.

11 Sep 2006

Court of Appeals rules in favor of Mylan in Oxybutynin patent case

Mylan Laboratories Inc. has announced that the U.S. Court of Appeals for the Federal Circuit upheld a district court decision that Mylan's Oxybutynin products do not infringe a patent for DITROPAN XL and that the patent was invalid.

11 Sep 2006

Some drug companies experiencing higher prescription volume, revenue with Medicare drug benefit

The Philadelphia Inquirer on Monday examined how the Medicare prescription drug benefit "is boosting prescription volume and revenue for drug companies."

5 Sep 2006

Pfizer wins Norvasc patent challenge

Pfizer has said that a federal court in the Middle District of North Carolina has upheld the company's U.S. patent covering amlodipine besylate, the active ingredient in Norvasc, the world's most-prescribed branded medicine for treating hypertension.

4 Sep 2006

Ranbaxy wins two additional Atorvastatin patents in Norway

Ranbaxy Laboratories Limited has announced that a Norwegian court handed down a favorable decision for Ranbaxy in its case against Pfizer, involving two patents on atorvastatin in Norway.

30 Aug 2006

Temple in Thailand providing HIV/AIDS services set to close

A temple in Thailand that provides medical care and shelter for HIV-positive people within three months is scheduled to close because of a lack of public resources, according to Chalermphol Pholmuk, secretary-general of the Dharmarak Foundation, the Bangkok Post reports.

30 Aug 2006

Ortho-McNeil to lower the price of contraceptive pills and patches

Ortho-McNeil - which supplies contraceptives to the majority of family planning clinics nationwide - on Thursday announced it will lower the price of its contraceptive pills and patches, according to officials, the Chicago Tribune reports.

30 Aug 2006

New York Times profiles Clinton's role in fight against HIV/AIDS

The New York Times on Tuesday profiled former President Clinton's role in the fight against HIV/AIDS in Africa, as well as in the rest of the world.

30 Aug 2006

FDA approves generic Ciprofloxacin injection

The Food and Drug Administration has approved several Abbreviated New Drug Applications (ANDAs) for generic versions of Bayer Corporation Pharmaceutical Division's CIPRO I.V., a drug to treat certain bacterial infections.

29 Aug 2006

West Virginia revisions to Medicaid programs examined

NPR's "Morning Edition" on Tuesday examined revisions to the Medicaid programs in Kentucky and West Virginia, which are the first two states to revise their programs under a new federal law that allows states increased flexibility in determining benefits and out-of-pocket costs (Rovner, "Morning Edition," NPR, 8/22).

24 Aug 2006

HIV-positive people in developing countries risk having no antiretroviral treatment

Hundreds of thousands of HIV-positive people in developing countries in a few years will have no antiretroviral drug treatment unless more focus is placed on drug costs and access, HIV/AIDS advocates said Wednesday at the XVI International AIDS Conference in Toronto, Toronto's Globe and Mail reports.

20 Aug 2006